PALMIERI, RAFFAELE
PALMIERI, RAFFAELE
Acute Leukemia diagnosis during the Covid-19 pandemic
2023-01-01 Guarnera, L; Buzzatti, E; Marchesi, F; Armiento, D; Mazzone, C; Capria, S; Scalzulli, E; Malfona, F; Chiaretti, S; Palmieri, R; Paterno, G; Franzese, C; Bonanni, F; Savi, A; Pasqualone, G; Moretti, F; Maurillo, L; Buccisano, F; Venditti, A; DEL PRINCIPE, Mi
Acute Myeloid Leukemia with Concomitant BCR-ABL and NPM1 Mutations
2019-01-01 Mariotti, B; Meconi, F; Palmieri, R; De Bellis, E; Lavorgna, S; Ottone, T; Martini, V; Lo-Coco, F; Cicconi, L
An evaluation of enasidenib for the treatment of acute myeloid leukemia
2019-08-27 Del Principe, Mi; Paterno, G; Palmieri, R; Maurillo, L; Buccisano, F; Venditti, A
An Polycythemia Vera Evolve from Acute Myeloid Leukemia? Report of a Case Showing a Simultaneous Minor JAK2 V617F Mutated Clone
2022-01-01 Borsellino, B; Savi, A; Pascale, M; Meddi, E; Del Principe, M; Cristiano, A; Ottone, T; Rapanotti, M; Divona, M; Travaglini, S; Attardi, E; Palmieri, R; Buzzatti, E; Buccisano, F; Voso, M
Baseline T-lymphocyte subset absolute counts can predict both outcome and severity in {SARS}-{CoV}-2 infected patients: a single center study
2021-06-01 Iannetta, M; Buccisano, F; Fraboni, D; Malagnino, V; Campogiani, L; Teti, E; Spalliera, I; Rossi, B; Di Lorenzo, A; Palmieri, R; Crea, A; Zordan, M; Vitale, P; Voso, Mt; Andreoni, M; Sarmati, L
Case report: A Saprochaete clavata (Magnusiomyces clavatus) severe infection effectively treated with granulocyte transfusion in a young patient with myeloid sarcoma
2022-01-01 Pasqualone, G; Buzzatti, E; Palmieri, R; Savi, A; Pascale, Mr; Borsellino, B; Guarnera, L; Buccisano, F; Voso, Mt; Maurillo, L; Sconocchia, G; Venditti, A; Del Principe, Mi
CD34 + CD38-CLL1+ leukemic stem cells persistence measured by multiparametric flow cytometry is a biomarker of poor prognosis in adult patients with acute myeloid leukemia
2021-11-21 Palmieri, R; Buccisano, F; Arena, V; Irno Consalvo, Ma; Piciocchi, A; Maurillo, L; Delprincipe, Mi; Di Veroli, A; Paterno, G; Conti, C; Fraboni, D; Voso, Mt; Arcese, W; Venditti, A
CD99 as a novel therapeutic target on leukemic progenitor cells in FLT3-ITDmut AML
2022-01-01 Travaglini, S; Ottone, T; Angelini, Df; Fiori, V; Dominici, S; Noguera, Ni; Sniegocka, M; Antonelli, S; Irno Consalvo, Ma; De Bardi, M; Banella, C; Divona, M; Marchesi, F; Masciarelli, S; Fazi, F; Pieraccioli, M; Palmieri, R; De Angelis, G; Buccisano, F; Venditti, A; Battistini, L; Magnani, M; Voso, Mt
Clinical relevance of an objective - limit of detection - limit of quantification - based flow cytometry approach for measurable residual disease assessment in acute myeloid leukemia. A post-hoc analysis of the GIMEMA AML1310 trial
2022-03-17 Buccisano, F; Palmieri, R; Piciocchi, A; Arena, V; Maurillo, L; Del Principe, M; Paterno, G; Irno-Consalvo, M; Ottone, T; Divona, M; Conti, C; Fraboni, D; Lavorgna, S; Arcese, W; Voso, Mt; Venditti, A
Comparison between azacitidine and decitabine as front-line therapy in elderly acute myeloid leukemia patients not eligible for intensive chemotherapy
2023-02-14 Maurillo, L; Spagnoli, A; Candoni, A; Papayannidis, C; Borlenghi, E; Lazzarotto, D; Fianchi, L; Sciumè, M; Zannier, Me; Buccisano, F; Del Principe, Mi; Mancini, V; Breccia, M; Fanin, R; Todisco, E; Lunghi, M; Palmieri, R; Fracchiolla, N; Musto, P; Rossi, G; Venditti, A
Current strategies for detection and approach to measurable residual disease in Acute Myeloid Leukemia
2020-01-01 Palmieri, R; Buccisano, F; Maurillo, L; Del Principe, Mi; Paterno, G; Venditti, A; Martinelli, G; Cerchione, C
DIAGNOSTIC PERFORMANCE AND SAFETY OF BRONCHOALVEOLAR LAVAGE IN THROMBOCYTOPENIC HAEMATOLOGICAL PATIENTS FOR ASPERGILLOSIS DIAGNOSIS: A MONOCENTRIC, RETROSPECTIVE EXPERIENCE
2019-11-01 Del Principe, Mi; Venditti, A; Arcese, W; Cantonetti, M; Buccisano, F; Maurillo, L; De Fabritiis, P; Rogliani, P; Zizzari, Ag; Casciani, P; Laureana, R; Meconi, F; Buzzatti, E; Palmieri, R; De Bellis, E; Pane, G; Nassa, D; Fontana, C; Paterno, G; Sarmati, L; Puxeddu, E; Cefalo, M
Editorial: Measurable residual disease in hematologic malignancies
2023-01-01 Buccisano, F; Palmieri, R; Guzman, Ml; Galimberti, S
ELN2017 risk stratification improves outcome prediction when applied to the prospective GIMEMA AML1310 protocol
2022-01-01 Buccisano, F; Palmieri, R; Piciocchi, A; Arena, V; Candoni, A; Melillo, L; Calafiore, V; Cairoli, R; De Fabritiis, P; Storti, G; Salutari, P; Lanza, F; Martinelli, G; Luppi, M; Capria, S; Maurillo, L; Del Principe, Mi; Paterno, G; Irno Consalvo, Ma; Ottone, T; Lavorgna, S; Voso, Mt; Fazi, P; Vignetti, M; Arcese, W; Venditti, A
FEVER OF UNKNOWN ORIGIN AND MULTIDRUG-RESISTANT ORGANISMS COLONIZATION IN AML PATIENTS
2023-01-01 Guarnera, L; Trotta, Ge; Boldrini, V; Cardillo, L; Cerroni, I; Mezzanotte, V; Pasqualone, G; Savi, A; Borsellino, B; Buzzatti, E; Palmieri, R; Paterno, G; Maurillo, L; Buccisano, F; Venditti, A; Del Principe, Mi
Impairment of FOXM1 expression in mesenchymal cells from patients with myeloid neoplasms, de novo and therapy-related, may compromise their ability to support hematopoiesis
2022-12-08 Falconi, G; Galossi, E; Fabiani, E; Pieraccioli, M; Travaglini, S; Hajrullaj, H; Cerretti, R; Palmieri, R; Latagliata, R; Maurillo, L; Voso, Mt
In BCR-ABL1 Positive B-Cell Acute Lymphoblastic Leukemia, Steroid Therapy Induces Hypofibrinogenemia
2022-03-23 Buzzatti, E; Forghieri, F; Paterno, G; Marchesi, F; Sarlo, C; Giglio, F; Fracchiolla, N; Sciumè, M; Palmieri, R; Esposito, F; Guarnera, L; Mercante, L; Pascale, Mr; Mallegni, F; Savi, A; Forte, V; Maurillo, L; Buccisano, F; Venditti, A; Del Principe, Mi
Increased Plasma Levels of lncRNAs LINC01268, GAS5 and MALAT1 Correlate with Negative Prognostic Factors in Myelofibrosis
2021-09-22 Fantini, S; Rontauroli, S; Sartini, S; Mirabile, M; Bianchi, E; Badii, F; Maccaferri, M; Guglielmelli, P; Ottone, T; Palmieri, R; Genovese, E; Carretta, C; Parenti, S; Mallia, S; Tavernari, L; Salvadori, C; Gesullo, F; Maccari, C; Zizza, M; Grande, A; Salmoiraghi, S; Mora, B; Potenza, L; Rosti, V; Passamonti, F; Rambaldi, A; Voso, Mt; Mecucci, C; Tagliafico, E; Luppi, M; Vannucchi, Am; Manfredini, R
Literature review and expert opinion on the treatment of high-risk acute myeloid leukemia in patients who are eligible for intensive chemotherapy
2024-02-20 Palmieri, R; Billio, A; Ferrara, F; Galimberti, S; Lemoli, Rm; Todisco, E; Moretti, F; Venditti, A
Measurable Residual Disease (MRD) as a Surrogate Efficacy-Response Biomarker in AML
2023-02-04 Meddi, E; Savi, A; Moretti, F; Mallegni, F; Palmieri, R; Paterno, G; Buzzatti, E; Del Principe, Mi; Buccisano, F; Venditti, A; Maurillo, L
| Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
|---|---|---|---|---|
| 1-gen-2023 | Acute Leukemia diagnosis during the Covid-19 pandemic | Guarnera, L; Buzzatti, E; Marchesi, F; Armiento, D; Mazzone, C; Capria, S; Scalzulli, E; Malfona, F; Chiaretti, S; Palmieri, R; Paterno, G; Franzese, C; Bonanni, F; Savi, A; Pasqualone, G; Moretti, F; Maurillo, L; Buccisano, F; Venditti, A; DEL PRINCIPE, Mi | Articolo su rivista | |
| 1-gen-2019 | Acute Myeloid Leukemia with Concomitant BCR-ABL and NPM1 Mutations | Mariotti, B; Meconi, F; Palmieri, R; De Bellis, E; Lavorgna, S; Ottone, T; Martini, V; Lo-Coco, F; Cicconi, L | Articolo su rivista | |
| 27-ago-2019 | An evaluation of enasidenib for the treatment of acute myeloid leukemia | Del Principe, Mi; Paterno, G; Palmieri, R; Maurillo, L; Buccisano, F; Venditti, A | Articolo su rivista | |
| 1-gen-2022 | An Polycythemia Vera Evolve from Acute Myeloid Leukemia? Report of a Case Showing a Simultaneous Minor JAK2 V617F Mutated Clone | Borsellino, B; Savi, A; Pascale, M; Meddi, E; Del Principe, M; Cristiano, A; Ottone, T; Rapanotti, M; Divona, M; Travaglini, S; Attardi, E; Palmieri, R; Buzzatti, E; Buccisano, F; Voso, M | Articolo su rivista | |
| 1-giu-2021 | Baseline T-lymphocyte subset absolute counts can predict both outcome and severity in {SARS}-{CoV}-2 infected patients: a single center study | Iannetta, M; Buccisano, F; Fraboni, D; Malagnino, V; Campogiani, L; Teti, E; Spalliera, I; Rossi, B; Di Lorenzo, A; Palmieri, R; Crea, A; Zordan, M; Vitale, P; Voso, Mt; Andreoni, M; Sarmati, L | Articolo su rivista | |
| 1-gen-2022 | Case report: A Saprochaete clavata (Magnusiomyces clavatus) severe infection effectively treated with granulocyte transfusion in a young patient with myeloid sarcoma | Pasqualone, G; Buzzatti, E; Palmieri, R; Savi, A; Pascale, Mr; Borsellino, B; Guarnera, L; Buccisano, F; Voso, Mt; Maurillo, L; Sconocchia, G; Venditti, A; Del Principe, Mi | Articolo su rivista | |
| 21-nov-2021 | CD34 + CD38-CLL1+ leukemic stem cells persistence measured by multiparametric flow cytometry is a biomarker of poor prognosis in adult patients with acute myeloid leukemia | Palmieri, R; Buccisano, F; Arena, V; Irno Consalvo, Ma; Piciocchi, A; Maurillo, L; Delprincipe, Mi; Di Veroli, A; Paterno, G; Conti, C; Fraboni, D; Voso, Mt; Arcese, W; Venditti, A | Articolo su rivista | |
| 1-gen-2022 | CD99 as a novel therapeutic target on leukemic progenitor cells in FLT3-ITDmut AML | Travaglini, S; Ottone, T; Angelini, Df; Fiori, V; Dominici, S; Noguera, Ni; Sniegocka, M; Antonelli, S; Irno Consalvo, Ma; De Bardi, M; Banella, C; Divona, M; Marchesi, F; Masciarelli, S; Fazi, F; Pieraccioli, M; Palmieri, R; De Angelis, G; Buccisano, F; Venditti, A; Battistini, L; Magnani, M; Voso, Mt | Articolo su rivista | |
| 17-mar-2022 | Clinical relevance of an objective - limit of detection - limit of quantification - based flow cytometry approach for measurable residual disease assessment in acute myeloid leukemia. A post-hoc analysis of the GIMEMA AML1310 trial | Buccisano, F; Palmieri, R; Piciocchi, A; Arena, V; Maurillo, L; Del Principe, M; Paterno, G; Irno-Consalvo, M; Ottone, T; Divona, M; Conti, C; Fraboni, D; Lavorgna, S; Arcese, W; Voso, Mt; Venditti, A | Articolo su rivista | |
| 14-feb-2023 | Comparison between azacitidine and decitabine as front-line therapy in elderly acute myeloid leukemia patients not eligible for intensive chemotherapy | Maurillo, L; Spagnoli, A; Candoni, A; Papayannidis, C; Borlenghi, E; Lazzarotto, D; Fianchi, L; Sciumè, M; Zannier, Me; Buccisano, F; Del Principe, Mi; Mancini, V; Breccia, M; Fanin, R; Todisco, E; Lunghi, M; Palmieri, R; Fracchiolla, N; Musto, P; Rossi, G; Venditti, A | Articolo su rivista | |
| 1-gen-2020 | Current strategies for detection and approach to measurable residual disease in Acute Myeloid Leukemia | Palmieri, R; Buccisano, F; Maurillo, L; Del Principe, Mi; Paterno, G; Venditti, A; Martinelli, G; Cerchione, C | Articolo su rivista | |
| 1-nov-2019 | DIAGNOSTIC PERFORMANCE AND SAFETY OF BRONCHOALVEOLAR LAVAGE IN THROMBOCYTOPENIC HAEMATOLOGICAL PATIENTS FOR ASPERGILLOSIS DIAGNOSIS: A MONOCENTRIC, RETROSPECTIVE EXPERIENCE | Del Principe, Mi; Venditti, A; Arcese, W; Cantonetti, M; Buccisano, F; Maurillo, L; De Fabritiis, P; Rogliani, P; Zizzari, Ag; Casciani, P; Laureana, R; Meconi, F; Buzzatti, E; Palmieri, R; De Bellis, E; Pane, G; Nassa, D; Fontana, C; Paterno, G; Sarmati, L; Puxeddu, E; Cefalo, M | Articolo su rivista | |
| 1-gen-2023 | Editorial: Measurable residual disease in hematologic malignancies | Buccisano, F; Palmieri, R; Guzman, Ml; Galimberti, S | Articolo su rivista | |
| 1-gen-2022 | ELN2017 risk stratification improves outcome prediction when applied to the prospective GIMEMA AML1310 protocol | Buccisano, F; Palmieri, R; Piciocchi, A; Arena, V; Candoni, A; Melillo, L; Calafiore, V; Cairoli, R; De Fabritiis, P; Storti, G; Salutari, P; Lanza, F; Martinelli, G; Luppi, M; Capria, S; Maurillo, L; Del Principe, Mi; Paterno, G; Irno Consalvo, Ma; Ottone, T; Lavorgna, S; Voso, Mt; Fazi, P; Vignetti, M; Arcese, W; Venditti, A | Articolo su rivista | |
| 1-gen-2023 | FEVER OF UNKNOWN ORIGIN AND MULTIDRUG-RESISTANT ORGANISMS COLONIZATION IN AML PATIENTS | Guarnera, L; Trotta, Ge; Boldrini, V; Cardillo, L; Cerroni, I; Mezzanotte, V; Pasqualone, G; Savi, A; Borsellino, B; Buzzatti, E; Palmieri, R; Paterno, G; Maurillo, L; Buccisano, F; Venditti, A; Del Principe, Mi | Articolo su rivista | |
| 8-dic-2022 | Impairment of FOXM1 expression in mesenchymal cells from patients with myeloid neoplasms, de novo and therapy-related, may compromise their ability to support hematopoiesis | Falconi, G; Galossi, E; Fabiani, E; Pieraccioli, M; Travaglini, S; Hajrullaj, H; Cerretti, R; Palmieri, R; Latagliata, R; Maurillo, L; Voso, Mt | Articolo su rivista | |
| 23-mar-2022 | In BCR-ABL1 Positive B-Cell Acute Lymphoblastic Leukemia, Steroid Therapy Induces Hypofibrinogenemia | Buzzatti, E; Forghieri, F; Paterno, G; Marchesi, F; Sarlo, C; Giglio, F; Fracchiolla, N; Sciumè, M; Palmieri, R; Esposito, F; Guarnera, L; Mercante, L; Pascale, Mr; Mallegni, F; Savi, A; Forte, V; Maurillo, L; Buccisano, F; Venditti, A; Del Principe, Mi | Articolo su rivista | |
| 22-set-2021 | Increased Plasma Levels of lncRNAs LINC01268, GAS5 and MALAT1 Correlate with Negative Prognostic Factors in Myelofibrosis | Fantini, S; Rontauroli, S; Sartini, S; Mirabile, M; Bianchi, E; Badii, F; Maccaferri, M; Guglielmelli, P; Ottone, T; Palmieri, R; Genovese, E; Carretta, C; Parenti, S; Mallia, S; Tavernari, L; Salvadori, C; Gesullo, F; Maccari, C; Zizza, M; Grande, A; Salmoiraghi, S; Mora, B; Potenza, L; Rosti, V; Passamonti, F; Rambaldi, A; Voso, Mt; Mecucci, C; Tagliafico, E; Luppi, M; Vannucchi, Am; Manfredini, R | Articolo su rivista | |
| 20-feb-2024 | Literature review and expert opinion on the treatment of high-risk acute myeloid leukemia in patients who are eligible for intensive chemotherapy | Palmieri, R; Billio, A; Ferrara, F; Galimberti, S; Lemoli, Rm; Todisco, E; Moretti, F; Venditti, A | Articolo su rivista | |
| 4-feb-2023 | Measurable Residual Disease (MRD) as a Surrogate Efficacy-Response Biomarker in AML | Meddi, E; Savi, A; Moretti, F; Mallegni, F; Palmieri, R; Paterno, G; Buzzatti, E; Del Principe, Mi; Buccisano, F; Venditti, A; Maurillo, L | Articolo su rivista |